Skip to content

Welcome to Discover Pharma! Today is : November 11, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Clinical & Regulatory

  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Amorphical names Eden Ben CEO to drive regulatory strategy and expand nano-mineral therapeutics pipeline

    Amorphical has appointed Eden Ben as chief executive officer, as [...]

    May 5, 2026
  • Clinical & Regulatory,Opinion & Events,Therapeutic Areas

    UK clears Mainz Biomed’s ColoAlert for colorectal cancer screening

    Mainz Biomed has received official registration from the UK Medicines [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory

    Vitalant and UPMC expand partnership to advance cell and gene therapy initiatives

    Vitalant, a national blood and biotherapies provider, is expanding its [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    More than 450 companies adopt Veeva RIM to accelerate regulatory submissions

    Veeva Systems announced today that more than 450 companies, including [...]

    May 5, 2026
  • Clinical & Regulatory,Therapeutic Areas

    From symptoms to biology: Neurodegeneration in the paraventricular thalamus in bipolar disorder

    Accumulation of neurodegenerative proteins could be key to understanding bipolar [...]

    May 5, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics

    MHRA grants Promising Innovative Medicine designation to TransCon CNP for achondroplasia

    Ascendis Pharma UK Limited announced that TransCon CNP (navepegritide) has [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    NRG Therapeutics closes oversubscribed £50m series B to advance clinical data in Parkinson’s and proof of concept in ALS/MND

    NRG Therapeutics Ltd, a neuroscience company developing treatments targeting mitochondrial [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Biostate AI launches K-Dense beta to accelerate biological discovery from years to days

    Biostate AI has launched K-Dense Beta, a multi-agent AI system [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    SynGenSys launches NK.SET synthetic promoter library to support NK cell therapy development

    SynGenSys, a biotechnology company developing synthetic gene promoter systems, has [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    NICE recommends Johnson & Johnson’s TREMFYA for Crohn’s disease and ulcerative colitis in the UK

    The National Institute for Health and Care Excellence (NICE) has [...]

    May 5, 2026
Previous575859Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • DNA Script and GE HealthCare awarded up to $26M for DNA bioproduction programme
    Categories: Genomics and sequencing, Manufacturing & Supply Chain, Research & Development
  • Vaximm reports encouraging VXM01 data in recurrent glioblastoma studies
    Categories: Central Nervous System, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development
  • Aravax’s PVX108 wins FDA Fast Track designation for peanut allergy
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top